240 related articles for article (PubMed ID: 25248675)
1. Induced pluripotent stem cells (iPSCs) in the modeling of hepatitis C virus infection.
Cheng L; Zhang Y; Nan Y; Qiao L
Curr Stem Cell Res Ther; 2015; 10(3):216-9. PubMed ID: 25248675
[TBL] [Abstract][Full Text] [Related]
2. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
4. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
5. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation.
Wu X; Robotham JM; Lee E; Dalton S; Kneteman NM; Gilbert DM; Tang H
PLoS Pathog; 2012; 8(4):e1002617. PubMed ID: 22496645
[TBL] [Abstract][Full Text] [Related]
6. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection.
Yoshida T; Takayama K; Kondoh M; Sakurai F; Tani H; Sakamoto N; Matsuura Y; Mizuguchi H; Yagi K
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):119-24. PubMed ID: 22093821
[TBL] [Abstract][Full Text] [Related]
7. Development of Hepatocyte-like Cell Derived from Human Induced Pluripotent Stem cell as a Host for Clinically Isolated Hepatitis C Virus.
Sa-Ngiamsuntorn K; Hongeng S; Wongkajornsilp A
Curr Protoc Stem Cell Biol; 2017 Aug; 42(1):4A.13.1-4A.13.34. PubMed ID: 28806853
[TBL] [Abstract][Full Text] [Related]
8. Humanized murine model for HBV and HCV using human induced pluripotent stem cells.
Zhou XL; Sullivan GJ; Sun P; Park IH
Arch Pharm Res; 2012 Feb; 35(2):261-9. PubMed ID: 22370780
[TBL] [Abstract][Full Text] [Related]
9. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
[TBL] [Abstract][Full Text] [Related]
10. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model.
Carpentier A; Tesfaye A; Chu V; Nimgaonkar I; Zhang F; Lee SB; Thorgeirsson SS; Feinstone SM; Liang TJ
J Clin Invest; 2014 Nov; 124(11):4953-64. PubMed ID: 25295540
[TBL] [Abstract][Full Text] [Related]
11. Embryonic or Induced Pluripotent Stem Cell-Derived Hepatocellular Systems for HCV Culture.
Wu X; Dao Thi VL
Methods Mol Biol; 2019; 1911():121-135. PubMed ID: 30593622
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.
Scull MA; Shi C; de Jong YP; Gerold G; Ries M; von Schaewen M; Donovan BM; Labitt RN; Horwitz JA; Gaska JM; Hrebikova G; Xiao JW; Flatley B; Fung C; Chiriboga L; Walker CM; Evans DT; Rice CM; Ploss A
Hepatology; 2015 Jul; 62(1):57-67. PubMed ID: 25820364
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells.
Sakurai F; Kunito T; Takayama K; Hashimoto R; Tachibana M; Sakamoto N; Wakita T; Mizuguchi H
Virus Res; 2017 Oct; 242():7-15. PubMed ID: 28893653
[TBL] [Abstract][Full Text] [Related]
14. Potential applications of induced pluripotent stem cells (iPSCs) in hepatology research.
Sun C; Wilson GS; Fan JG; Qiao L
Curr Stem Cell Res Ther; 2015; 10(3):208-15. PubMed ID: 25599714
[TBL] [Abstract][Full Text] [Related]
15. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.
Schöbel A; Rösch K; Herker E
Sci Rep; 2018 Mar; 8(1):3893. PubMed ID: 29497123
[TBL] [Abstract][Full Text] [Related]
16. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
[TBL] [Abstract][Full Text] [Related]
17. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
18. New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.
Jee MH; Hong KY; Park JH; Lee JS; Kim HS; Lee SH; Jang SK
J Virol; 2015 Dec; 90(6):3044-55. PubMed ID: 26719248
[TBL] [Abstract][Full Text] [Related]
19. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus.
Roelandt P; Obeid S; Paeshuyse J; Vanhove J; Van Lommel A; Nahmias Y; Nevens F; Neyts J; Verfaillie CM
J Hepatol; 2012 Aug; 57(2):246-51. PubMed ID: 22521345
[TBL] [Abstract][Full Text] [Related]
20. Impact of immune response on the use of iPSCs in disease modeling.
Zhang Z; Huang B; Gao F; Zhang R
Curr Stem Cell Res Ther; 2015; 10(3):236-44. PubMed ID: 25019961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
